KRAS and ovarian clear cell cancer: Notably, recent genome sequencing studies reported frequent mutations of ARID1A and PIK3CA genes and moderate mutations of PPP2R1A and KRAS in ovarian clear-cell carcinomas [51, 52] and frequent mutations of PTEN, CTNNB1, and KRAS in endometrioid cancer [53, 54].